These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32076890)

  • 1. 2
    Pawar S; Shende P
    Biomed Microdevices; 2020 Feb; 22(1):19. PubMed ID: 32076890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
    Parashar D; Aditya NP; Murthy RS
    Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.
    Yang Y; Gao H; Zhou S; Kuang X; Wang Z; Liu H; Sun J
    Drug Deliv Transl Res; 2018 Oct; 8(5):1171-1179. PubMed ID: 29748832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery.
    Shakeel K; Raisuddin S; Ali S; Imam SS; Rahman MA; Jain GK; Ahmad FJ
    J Liposome Res; 2019 Mar; 29(1):35-43. PubMed ID: 29179636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoliposomes Embedded Nanocochleates for Codelivery of Artemether and Lumefantrine: An
    Mathure D; Sonawane P; Ranpise H; Awasthi R
    Assay Drug Dev Technol; 2024; 22(2):63-72. PubMed ID: 38193797
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of immunopotentiation using tetanus toxoid-based nanoparticulate dissolvable microneedles.
    Waghchaure M; Govardhane S; Shende P
    Biomed Microdevices; 2021 Jun; 23(3):32. PubMed ID: 34181103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches.
    Anjani QK; Sabri AHB; Utomo E; Domínguez-Robles J; Donnelly RF
    Mol Pharm; 2022 Apr; 19(4):1191-1208. PubMed ID: 35235330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and mechanical modelling of dissolvable PVA/PVP composite microneedles with biocompatibility for efficient transdermal delivery of ibuprofen.
    Xiao M; Wang Z; An Y; Dai Y; Wang X; Zhu Z
    J Biomater Sci Polym Ed; 2024 Jun; 35(9):1439-1454. PubMed ID: 38590076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Artemether and Lumefantrine Dual Drug Loaded Lipid Nanoparticles: Physicochemical Characterization, Pharmacokinetic Evaluation and Biodistribution Study.
    Shakeel K; Ahmad FJ; Harwansh RK; Rahman MA
    Pharm Nanotechnol; 2022 Aug; ():. PubMed ID: 36029070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
    Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
    Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Novel Self-Dissolving Microneedle-Assisted Percutaneous Delivery System of Diacerein through Solid Dispersion Gel: Solubility Enhancement, Proof of Anti-inflammatory Activity and Safety.
    Shabbir M; Barkat K; Ashraf MU; Nagra U
    Curr Drug Deliv; 2023; 20(9):1351-1367. PubMed ID: 35770410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of Tip-Hollow and Tip-Dissolvable Microneedle Arrays for Transdermal Drug Delivery.
    Ye R; Yang J; Li Y; Zheng Y; Yang J; Li Y; Liu B; Jiang L
    ACS Biomater Sci Eng; 2020 Apr; 6(4):2487-2494. PubMed ID: 33455301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
    McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
    Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
    J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems.
    Cordeiro AS; Tekko IA; Jomaa MH; Vora L; McAlister E; Volpe-Zanutto F; Nethery M; Baine PT; Mitchell N; McNeill DW; Donnelly RF
    Pharm Res; 2020 Aug; 37(9):174. PubMed ID: 32856172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
    Chen MC; Ling MH; Lai KY; Pramudityo E
    Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin.
    Kumar A; Li X; Sandoval MA; Rodriguez BL; Sloat BR; Cui Z
    Int J Nanomedicine; 2011; 6():1253-64. PubMed ID: 21753877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model.
    Bhatnagar S; Bankar NG; Kulkarni MV; Venuganti VVK
    Int J Pharm; 2019 Feb; 556():263-275. PubMed ID: 30557681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.